Published in Lancet on December 28, 1974
Retrospective Study of Acanthamoebic Keratitis During the Past 10 Years | NCT02763605
Acanthamoeba spp. as agents of disease in humans. Clin Microbiol Rev (2003) 6.67
Cocultivation of Legionella pneumophila and free-living amoebae. Appl Environ Microbiol (1982) 2.75
Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol (1985) 2.18
The association of contact lens solution use and Acanthamoeba keratitis. Am J Ophthalmol (2007) 1.97
Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefes Arch Clin Exp Ophthalmol (2004) 1.83
Discrimination between clinically relevant and nonrelevant Acanthamoeba strains isolated from contact lens- wearing keratitis patients in Austria. J Clin Microbiol (2000) 1.53
Chemotherapeutic compounds and Acanthamoebae from eye infections. J Clin Pathol (1976) 1.45
Acanthamoeba migration in an electric field. Invest Ophthalmol Vis Sci (2013) 1.42
National outbreak of Acanthamoeba keratitis associated with use of a contact lens solution, United States. Emerg Infect Dis (2009) 1.36
Isolation of amoebae and Pseudomonas and Legionella spp. from eyewash stations. Appl Environ Microbiol (1991) 1.16
The role of domestic tap water in Acanthamoeba contamination in contact lens storage cases in Korea. Korean J Parasitol (2005) 1.15
Blindness due to Acanthamoeba: first case report from Sudan. Int J Health Sci (Qassim) (2008) 1.10
Differentiation of Acanthamoeba strains from infected corneas and the environment by using restriction endonuclease digestion of whole-cell DNA. J Clin Microbiol (1991) 1.10
Application of flow cytometry to studies of pathogenic free-living amoebae. Appl Environ Microbiol (1982) 1.02
In vitro susceptibility of pathogenic Naegleria and Acanthamoeba speicies to a variety of therapeutic agents. Antimicrob Agents Chemother (1976) 0.99
Mitochondrial DNA restriction fragment length polymorphism (RFLP) and 18S small-subunit ribosomal DNA PCR-RFLP analyses of Acanthamoeba isolated from contact lens storage cases of residents in southwestern Korea. J Clin Microbiol (2002) 0.98
A case of radial keratoneuritis in non-Acanthamoeba keratitis. Clin Ophthalmol (2012) 0.98
Anti-Acanthamoeba activity of contact lens solutions. Br J Ophthalmol (1998) 0.97
Acanthamoeba keratitis: experience in a non-specialist microbiology laboratory. J Clin Pathol (1991) 0.97
Determination of amoebicidal activities of multipurpose contact lens solutions by using a most probable number enumeration technique. J Clin Microbiol (2003) 0.94
Acanthamoeba keratitis. Br J Ophthalmol (1987) 0.93
Genetic analyses of Acanthamoeba isolates from contact lens storage cases of students in Seoul, Korea. Korean J Parasitol (2001) 0.93
Experimental Acanthamoeba infections in mice pretreated with methylprednisolone or tetracycline. Am J Pathol (1978) 0.92
First report of an Acanthamoeba genotype T13 isolate as etiological agent of a keratitis in humans. Parasitol Res (2014) 0.92
Experimental Acanthamoeba keratitis: I. Preliminary findings. Br J Ophthalmol (1990) 0.90
Free-living protozoa in two unchlorinated drinking water supplies, identified by phylogenic analysis of 18S rRNA gene sequences. Appl Environ Microbiol (2009) 0.90
Granulomatous encephalitis, intracranial arteritis, and mycotic aneurysm due to a free-living ameba. Acta Neuropathol (1980) 0.89
Twenty years of acanthamoeba diagnostics in Austria. J Eukaryot Microbiol (2014) 0.88
Microsporidia and Acanthamoeba: the role of emerging corneal pathogens. Eye (Lond) (2011) 0.88
First Report of Hartmannella keratitis in a Cosmetic Soft Contact Lens Wearer in Iran. Iran J Parasitol (2013) 0.87
In vitro effectiveness of Thymus sipyleus subsp. sipyleus var. sipyleus on Acanthamoeba castellanii and its cytotoxic potential on corneal cells. Parasitol Res (2007) 0.86
A riboprinting scheme for identification of unknown Acanthamoeba isolates at species level. Korean J Parasitol (2002) 0.86
A retrospective study of nine cases of Acanthamoeba keratitis. Clin Ophthalmol (2010) 0.86
Acanthamoeba keratitis. Br Med J (Clin Res Ed) (1988) 0.84
Granulomatous amebic encephalitis presenting as a cerebral mass lesion. Acta Neuropathol (1980) 0.84
Free-living amoebae (FLA) co-occurring with legionellae in industrial waters. Eur J Protistol (2014) 0.84
Morphological, physiological and molecular biological characterisation of isolates from first cases of Acanthamoeba keratitis in Slovakia. Parasitol Res (2010) 0.83
Acanthamoeba keratitis: a 12-year experience covering a wide spectrum of presentations, diagnoses, and outcomes. J Ophthalmol (2013) 0.83
Acanthamoebic keratitis diagnosed by paracentesis and biopsy and treated with propamidine. Br J Ophthalmol (1987) 0.83
Advances in the diagnosis and treatment of acanthamoeba keratitis. J Ophthalmol (2012) 0.82
Genotypic characterization of amoeba isolated from Acanthamoeba keratitis in Poland. Parasitol Res (2015) 0.82
Keratitis by Acanthamoeba triangularis: report of cases and characterization of isolates. Korean J Parasitol (2008) 0.82
Results of case-control studies support the association between contact lens use and Acanthamoeba keratitis. Clin Ophthalmol (2013) 0.82
A case of medication-resistant acanthamoeba keratitis treated by corneal crosslinking in Turkey. Case Rep Ophthalmol Med (2013) 0.81
Diversity of microbial species implicated in keratitis: a review. Open Ophthalmol J (2012) 0.80
In vitro amoebicidal activity of four Allium species on Acanthamoeba castellanii and their cytotoxic potentials on corneal cells. Parasitol Res (2007) 0.80
Incidence and molecular diversity of Acanthamoeba species isolated from public baths in Hungary. Parasitol Res (2014) 0.79
Bowman's layer encystment in cases of persistent Acanthamoeba keratitis. Clin Ophthalmol (2012) 0.77
[Acanthamoeba keratitis]. Ophthalmologe (2013) 0.77
Protease-activated receptor 2 (PAR2) is upregulated by Acanthamoeba plasminogen activator (aPA) and induces proinflammatory cytokine in human corneal epithelial cells. Invest Ophthalmol Vis Sci (2014) 0.76
Ex vivo laser confocal microscopy findings of cultured Acanthamoeba trophozoites. Clin Ophthalmol (2012) 0.75
Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts. Clin Experiment Ophthalmol (2016) 0.75
Molecular detection of Acanthamoeba spp., Naegleria fowleri and Vermamoeba (Hartmannella) vermiformis as vectors for Legionella spp. in untreated and solar pasteurized harvested rainwater. Parasit Vectors (2016) 0.75
Chlorhexidine Monotherapy with Adjunctive Topical Corticosteroids for Acanthamoeba Keratitis. J Ophthalmic Vis Res (2015) 0.75
Medical interventions for acanthamoeba keratitis. Cochrane Database Syst Rev (2015) 0.75
Direct fungal infection of the eye and its prevention. Br J Ophthalmol (1976) 0.75
Role of protease-activated receptors 2 (PAR2) in ocular infections and inflammation. Receptors Clin Investig (2015) 0.75
Evaluation of the effectiveness of tea tree oil in treatment of Acanthamoeba infection. Parasitol Res (2017) 0.75
Emerging Threats for Human Health in Poland: Pathogenic Isolates from Drug Resistant Acanthamoeba Keratitis Monitored in terms of Their In Vitro Dynamics and Temperature Adaptability. Biomed Res Int (2015) 0.75
Radial keratoneuritis as a presenting sign in acanthamoeba keratitis. Middle East Afr J Ophthalmol (2011) 0.75
Characterisation and differentiation of pathogenic and non-pathogenic Acanthamoeba strains by their protein and antigen profiles. Parasitol Res (2004) 0.75
[Acanthamoeba keratitis in patients with contact lens wear in the Department of Ophthalmology in Debrecen]. Ophthalmologe (2010) 0.75
A simple system for the assessment of trachoma and its complications. Bull World Health Organ (1987) 12.27
Detection of Chlamydia (Bedsonia) in certain infections of man. II. Clinical study of genital tract, eye, rectum, and other sites of recovery of Chlamydia. J Infect Dis (1969) 6.76
Modification of the microimmunofluorescence test to provide a routine serodiagnostic test for chlamydial infection. J Clin Pathol (1977) 6.48
Chlamydial infection. Incidence in 'non-specific' urethritis. Br J Vener Dis (1972) 6.04
Blinding and non-blinding trachoma: assessment of intensity of upper tarsal inflammatory disease and disabling lesions. Bull World Health Organ (1975) 5.58
The prevention of blindness from trachoma. Trans Ophthalmol Soc U K (1975) 4.80
Infection by Bedsoniae and the possibility of spurious isolation. 2. Genital infection, disease of the eye, Reiter's disease. Am J Ophthalmol (1967) 4.73
Chlamydial infection. Results of micro-immunofluorescence tests for the detection of type-specific antibody in certain chlamydial infections. Br J Vener Dis (1972) 4.50
Conjunctival swabbing for the isolation of TRIC agent (Chlamydia). Br J Ophthalmol (1971) 4.01
Scleritis and episcleritis. Br J Ophthalmol (1976) 3.87
Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet (1993) 3.72
Dehydrational crises from severe diarrhoea or heatstroke and risk of cataract. Lancet (1984) 3.70
Chlamydial infection. Advances in the diagnostic isolation of Chlamydia, including TRIC agent, from the eye, genital tract, and rectum. Br J Vener Dis (1972) 3.41
TRIC agent as a cause of neonatal eye sepsis. Br Med J (1968) 2.90
Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers. Lancet (1979) 2.90
Ophthalmia nodosa. Br J Ophthalmol (1966) 2.80
Infection by TRIC agent and other members of the Bedsonia group; with a note on Reiter's disease. II. Ophthalmia neonatorum due to TRIC agent. Trans Ophthalmol Soc U K (1966) 2.46
Double-blind trial of the treatment of episcleritis-scleritis with oxyphenbutazone or prednisolone. Br J Ophthalmol (1966) 2.41
Clinical evaluation of trifluorothymidine in the treatment of herpes simplex corneal ulcers. Am J Ophthalmol (1972) 2.37
Repair of Descemet's membrane detachment after intraocular surgery. J Cataract Refract Surg (1995) 2.31
Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture. Am J Ophthalmol (1975) 2.29
Effect of high-speed centrifugation on the sensitivity of irradiated McCoy cell culture for the isolation of Chlamydia. Br J Vener Dis (1974) 2.28
Rapid serological test for diagnosis of chlamydial ocular infections. Br J Ophthalmol (1978) 2.25
Effectiveness of trabeculectomy in glaucoma. Am J Ophthalmol (1975) 2.20
Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol (1985) 2.18
Chlamydial infection. Results of tests for Chlamydia in patients suffering from acute Reiter's disease compared with results of tests of the genital tract and rectum in patients with ocular infection due to TRIC agent. Br J Vener Dis (1972) 2.15
Treatment of TRIC infection of the eye with rifampicin or chloramphenicol. Br J Ophthalmol (1977) 2.14
Punctate keratopathy of West Indians. Br J Ophthalmol (1968) 2.11
The management of ocular herpes. Trans Ophthalmol Soc U K (1967) 2.08
Ocular syndromes of TRIC virus infection and their possible genital significance. 1964. Sex Transm Infect (2000) 2.04
Posterior scleritis: clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology (1999) 2.02
HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP). Diabetes Care (2001) 1.99
Immunological classification of TRIC agents and of some recently isolated LGV agents by the micro-immunofluorescence test. Br J Vener Dis (1972) 1.95
Relation of TRIC agent to "non-specific genital infection". Br J Vener Dis (1966) 1.94
A comparison of topical acyclovir with steroids in the treatment of herpes zoster keratouveitis. Br J Ophthalmol (1983) 1.91
The place of trabeculectomy in the treatment of glaucoma. Ophthalmology (1981) 1.91
Private funding of elective hospital treatment in England and Wales, 1997-8: national survey. BMJ (2000) 1.90
Topical anaesthesia for phacoemulsification surgery. Eye (Lond) (1995) 1.86
Preliminary results of a physiologically based treatment of amblyopia. Br J Ophthalmol (1978) 1.84
Chlamydia and non-specific urethritis. Br Med J (1972) 1.82
Characterization of a further microimmunofluorescence serotype of Chlamydia: TRIC type G. Br J Vener Dis (1973) 1.82
Corneal and intra-ocular infection due to Fusarium solani. Trans Ophthalmol Soc U K (1970) 1.77
Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization. Bull World Health Organ (1998) 1.72
Isolation of TRIC agent (Chlamydia) in irradiated McCoy cell culture from endemic trachoma in field studies in Iran. Comparison with other laboratory tests for detection of Chlamydia. Br J Ophthalmol (1971) 1.72
Anterior segment fluorescein angiography in the diagnosis of scleral inflammation. Ophthalmology (1985) 1.68
Doyne Memorial Lecture, 1982. The nature and the treatment of scleral inflammation. Trans Ophthalmol Soc U K (1982) 1.64
Mycoplasmas and "non-specific" genital infection. II. Clinical aspects. Br J Vener Dis (1969) 1.63
Characterisation of rotaviruses from children treated at a London hospital during 1996: emergence of strains G9P2A[6] and G3P2A[6]. J Med Virol (2000) 1.59
Progression of scleral disease. Ophthalmology (1991) 1.59
Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study. Diabetes Care (1998) 1.58
Epidemic keratoconjunctivitis and chronic papillary conjunctivitis in London due to adenovirus type 19. Br J Ophthalmol (1977) 1.58
Smoking delays the response to treatment in episcleritis and scleritis. Eye (Lond) (2005) 1.56
Corticosteroids in the management of herpetic eye disease. Trans Ophthalmol Soc U K (1977) 1.54
Food sensitivity in cats with chronic idiopathic gastrointestinal problems. J Vet Intern Med (2001) 1.54
Management of acute primary angle-closure glaucoma: a long-term follow-up of the results of peripheral iridectomy used as an initial procedure. Br J Ophthalmol (1979) 1.53
Lacrimal canaliculitis due to Arachnia (Actinomyces) propionica. Br J Ophthalmol (1981) 1.53
Conjunctival impression cytology. Arch Ophthalmol (1977) 1.51
A survey of intraocular lens implantation in the United Kingdom. Trans Ophthalmol Soc U K (1985) 1.51
Congenital dermoid in a cat. N Z Vet J (1985) 1.50
Screening for refractive errors in 6-9 month old infants by photorefraction. Br J Ophthalmol (1984) 1.50
Visual loss due to posterior segment disease in scleritis. Trans Ophthalmol Soc U K (1975) 1.49
A comparison of acyclovir and idoxuridine as treatment for ulcerative herpetic keratitis. Br J Ophthalmol (1980) 1.49
Intravenous acyclovir in acute herpes zoster infection. J Infect (1983) 1.47
Effect of cyclosporin A on the survival of corneal grafts in rabbits. Br J Ophthalmol (1980) 1.44
Bilateral herpetic keratitis. Br J Ophthalmol (1981) 1.44
Laboratory tests for chlamydial infection. Their role in epidemiological studies of trachoma and its control. Br J Ophthalmol (1974) 1.44
Silver toxicity in an infant of strict vegan parents. J Pediatr Gastroenterol Nutr (2001) 1.43
Congenital myotonia in related kittens. J Small Anim Pract (1998) 1.41
A technique of keratoplasty for aphakic bullous keratopathy. Trans Ophthalmol Soc U K (1969) 1.40
Topical therapy of ulcerative herpetic keratitis with human interferon. Lancet (1976) 1.39
Chlamydial infection. Incidence in 'non-specific' urethritis. 1972. Sex Transm Infect (2000) 1.39
Strength of continuous spinal catheters. Anesth Analg (1991) 1.39
Feline leukaemia virus testing. N Z Vet J (1981) 1.39
Feline dysautonomia - the Key-Gaskell syndrome. N Z Vet J (1985) 1.39
Neisseria gonorrhoeae in Newcastle upon Tyne 1995-1997: increase in ciprofloxacin resistance. Int J STD AIDS (1999) 1.39
Social responsibilities in ophthalmology. J R Soc Med (1985) 1.39
General obstacles to the prevention of blindness. Trans Ophthalmol Soc U K (1978) 1.38
Perfusion pressure and electroencephalographic changes during cardiopulmonary bypass. J Clin Monit (1989) 1.38
Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers. Br J Ophthalmol (1981) 1.37
Infection by Bedsoniae and the possiblity of spurious isolation. I. Cross-infection of eggs during culture. Am J Ophthalmol (1967) 1.36
Neglected lid deformities causing progressive corneal disease. Surgical correction of entropion, trichiasis, marginal keratinization, and functional lid shortening. Trans Ophthalmol Soc U K (1976) 1.35
Evaluation of eyes enucleated for scleritis. Br J Ophthalmol (1976) 1.35
A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing. J Rheumatol (1993) 1.35
Infection by TRIC agent and other members of the Bedsonia group; with a note on Reiter's disease. 3. Genital infection and disease of the eye. Trans Ophthalmol Soc U K (1966) 1.35
Micro-immunofluorescence type-specific serological tests for chlamydial infection applied to psittacosis, ornithosis, lymphogranuloma venereum, trachoma, paratrachoma and 'nonspecific' urethritis. Proc R Soc Med (1974) 1.35
A comparison of various methods of treatment of amblyopia. A block study. Trans Ophthalmol Soc U K (1985) 1.34
The Arden grating test of visual function: a preliminary study of its practicability and application in a rural community in north-west Iran. Br J Ophthalmol (1978) 1.33
Regulation of membrane chloride currents in rat bile duct epithelial cells. J Clin Invest (1993) 1.33
Laboratory assessment of physical and chemical methods of preserving urine specimens. J Clin Pathol (1977) 1.31
Acute follicular conjunctivitis and keratoconjunctivitis due to herpes simplex virus in London. Br J Ophthalmol (1978) 1.30
Prospects of prevention of recurrent herpetic eye disease. Trans Ophthalmol Soc U K (1977) 1.30
Posterior scleritis: a clinical and histological survey. Eye (Lond) (1988) 1.30
Surgery of the glaucomas. Br J Ophthalmol (1972) 1.29
Clinical evaluation of adenine arabinoside and trifluorothymidine in the treatment of corneal ulcers caused by herpes simplex virus. J Infect Dis (1976) 1.29
The management of keratoconjuctivitis sicca. Trans Ophthalmol Soc U K (1965) 1.28
Infection by TRIC agent and other members of the Bedsonia group; with a note on Reiter's disease. I. Ocular disease in the adult. Trans Ophthalmol Soc U K (1966) 1.28
Role of debridement in the treatment of herpetic keratitis. Trans Ophthalmol Soc U K (1977) 1.27